Search - tctmd.com

Displaying 781 - 800 of 2896

Sort: Relevancy | Date

CVD Prevention and Control Remains a Challenge in India

News Daily News

CVD Prevention and Control Remains a Challenge in India

June 26, 2018

High CVD Risk in India Varies by State, Demographics

News Daily News

High CVD Risk in India Varies by State, Demographics

June 20, 2018

Serial CTA Shines a Light on Statin Effects in Subclinical CAD

News Daily News

Serial CTA Shines a Light on Statin Effects in Subclinical CAD

Yael L. Maxwell

June 15, 2018

The Patient Presenting With Chest Pain: Stress Echo Gives Coronary CTA a Run for Its Money

News Daily News

The Patient Presenting With Chest Pain: Stress Echo Gives Coronary CTA a Run for Its Money

Yael L. Maxwell

June 14, 2018

Platelet Reactivity Linked With Ischemic Stroke Risk Post-DES Implantation: ADAPT-DES Substudy

News Daily News

Platelet Reactivity Linked With Ischemic Stroke Risk Post-DES Implantation: ADAPT-DES Substudy

Yael L. Maxwell

June 08, 2018

Liability Reform Changes How Docs Manage Suspected Coronary Artery Disease

News Daily News

Liability Reform Changes How Docs Manage Suspected Coronary Artery Disease

Michael O'Riordan

June 07, 2018

Coronary CTA May Provide Novel Means of Predicting ACS Risk: ICONIC Study

News Daily News

Coronary CTA May Provide Novel Means of Predicting ACS Risk: ICONIC Study

June 01, 2018

One in Five ACS Patients Does Not Fill P2Y12 Inhibitor Prescription After PCI

News Daily News

One in Five ACS Patients Does Not Fill P2Y12 Inhibitor Prescription After PCI

Michael O'Riordan

May 21, 2018

ESC Consensus Statement Tackles Inflammation, Cholesterol Connection in a Post-CANTOS World

News Daily News

ESC Consensus Statement Tackles Inflammation, Cholesterol Connection in a Post-CANTOS World

May 16, 2018

Alirocumab Price Slashed in Deal With Express Scripts

News Daily News

Alirocumab Price Slashed in Deal With Express Scripts

Michael O'Riordan

May 03, 2018

Certain CAD Subgroups Without Severe HF Face Heightened Risk of Sudden Cardiac Death

News Daily News

Certain CAD Subgroups Without Severe HF Face Heightened Risk of Sudden Cardiac Death

May 02, 2018

Women Underrepresented in Pivotal Studies Leading to FDA Drug Approval

News Daily News

Women Underrepresented in Pivotal Studies Leading to FDA Drug Approval

Michael O'Riordan

May 01, 2018

FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen

News Daily News

FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen

Michael O'Riordan

April 25, 2018

Less Bleeding, Similar Outcomes With Dual vs Triple Therapy After PCI in Patients With A-fib

News Daily News

Less Bleeding, Similar Outcomes With Dual vs Triple Therapy After PCI in Patients With A-fib

April 24, 2018

FDA Advisors Take Fresh Look at Celecoxib Safety as PRECISION Aspirin Analysis Unveiled

News Daily News

FDA Advisors Take Fresh Look at Celecoxib Safety as PRECISION Aspirin Analysis Unveiled

Michael O'Riordan

April 24, 2018

Hybrid Coronary Revascularization at 5 Years: Similar Outcomes to CABG

News Daily News

Hybrid Coronary Revascularization at 5 Years: Similar Outcomes to CABG

Yael L. Maxwell

April 23, 2018

Nearly Half of Acute MI Patients Under Age 50 May Have Metabolic Syndrome

News Daily News

Nearly Half of Acute MI Patients Under Age 50 May Have Metabolic Syndrome

April 19, 2018

Silent MI Often Precedes Acute MI, Portends Worse Patient Outcomes

News Daily News

Silent MI Often Precedes Acute MI, Portends Worse Patient Outcomes

April 18, 2018

iFR Pullback Provides Roadmap for CAD Severity, Predicts Hemodynamics Post-PCI

News Daily News

iFR Pullback Provides Roadmap for CAD Severity, Predicts Hemodynamics Post-PCI

April 17, 2018

$Positive Real-World Results for Coronary Sinus Reducer in Patients With Refractory Angina$

News Daily News

Positive Real-World Results for Coronary Sinus Reducer in Patients With Refractory Angina

April 16, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.